Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-021-00517-0 |
id |
doaj-b43e08563253446ab56dc1107da98b2f |
---|---|
record_format |
Article |
spelling |
doaj-b43e08563253446ab56dc1107da98b2f2021-07-04T11:53:18ZengNature Publishing GroupBlood Cancer Journal2044-53852021-06-011161410.1038/s41408-021-00517-0Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experienceAhmad Nanaa0David Viswanatha1Zhuoer Xie2Dragan Jevremovic3Phuong Nguyen4Mohamad E. Salama5Patricia Greipp6Kurt Bessonen7Naseema Gangat8Mrinal Patnaik9Animesh Pardanani10Hassan B. Alkhateeb11Mithun Shah12William Hogan13Ayalew Tefferi14Mark Litzow15Rong He16Aref Al-Kali17Division of Hematology, Mayo ClinicDivision of Hematopathology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematopathology, Mayo ClinicDivision of Hematopathology, Mayo ClinicDivision of Hematopathology, Mayo ClinicDivision of Cytogenetics, Mayo ClinicDivision of Hematopathology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematopathology, Mayo ClinicDivision of Hematology, Mayo Clinichttps://doi.org/10.1038/s41408-021-00517-0 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ahmad Nanaa David Viswanatha Zhuoer Xie Dragan Jevremovic Phuong Nguyen Mohamad E. Salama Patricia Greipp Kurt Bessonen Naseema Gangat Mrinal Patnaik Animesh Pardanani Hassan B. Alkhateeb Mithun Shah William Hogan Ayalew Tefferi Mark Litzow Rong He Aref Al-Kali |
spellingShingle |
Ahmad Nanaa David Viswanatha Zhuoer Xie Dragan Jevremovic Phuong Nguyen Mohamad E. Salama Patricia Greipp Kurt Bessonen Naseema Gangat Mrinal Patnaik Animesh Pardanani Hassan B. Alkhateeb Mithun Shah William Hogan Ayalew Tefferi Mark Litzow Rong He Aref Al-Kali Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience Blood Cancer Journal |
author_facet |
Ahmad Nanaa David Viswanatha Zhuoer Xie Dragan Jevremovic Phuong Nguyen Mohamad E. Salama Patricia Greipp Kurt Bessonen Naseema Gangat Mrinal Patnaik Animesh Pardanani Hassan B. Alkhateeb Mithun Shah William Hogan Ayalew Tefferi Mark Litzow Rong He Aref Al-Kali |
author_sort |
Ahmad Nanaa |
title |
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience |
title_short |
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience |
title_full |
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience |
title_fullStr |
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience |
title_full_unstemmed |
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience |
title_sort |
clinical and biological characteristics and prognostic impact of somatic gata2 mutations in myeloid malignancies: a single institution experience |
publisher |
Nature Publishing Group |
series |
Blood Cancer Journal |
issn |
2044-5385 |
publishDate |
2021-06-01 |
url |
https://doi.org/10.1038/s41408-021-00517-0 |
work_keys_str_mv |
AT ahmadnanaa clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT davidviswanatha clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT zhuoerxie clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT draganjevremovic clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT phuongnguyen clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT mohamadesalama clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT patriciagreipp clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT kurtbessonen clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT naseemagangat clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT mrinalpatnaik clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT animeshpardanani clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT hassanbalkhateeb clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT mithunshah clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT williamhogan clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT ayalewtefferi clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT marklitzow clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT ronghe clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience AT arefalkali clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience |
_version_ |
1721319876548624384 |